The UK is investing heavily in preparation for mass manufacturing of a working COVID-19 vaccine.
The COVID-19 Emergency Response Act enables compulsory drug licensing to help avoid medication shortages.
Toilet paper shortages were bad enough. A shortage of drugs during the COVID-19 pandemic would be worse. A provision in the Canadian government's relief package aims to prevent that from happening.
The pipeline of pharmaceuticals is easily disrupted.
Gumpanat/iStock via Getty Images Plus
Drug shortages occur regularly in the US, even in the best of times. The pharmaceutical supply chain embodies 'just in time' shipping and has little built-in redundancy.
Doctors’ prescribing habits are influenced by drug reps and other industry marketing.
Monkey Business Images/Shutterstock
Too often, pharmaceutical companies and device manufacturers exert influence in how their products are tested in the research phase and recommended in the clinic.
The government should work with drug companies, not against them.
Greenhouse gas emissions from pharmaceutical companies need to be better monitored and regulated.
The first study to assess the carbon footprint of the pharmaceutical industry finds that it is far from green.
Tax breaks or exemptions for those working in pharmacy, health insurance and pharmaceutical industries could help bolster support for a national pharmacare plan.
Two community pharmacists suggest a way for improving the palatability of evidence-based universal pharmacare -- for those working in health insurance, pharmacy and the pharmaceutical industry.
No longer tangled and pointing in the right direction.
Fixes for small pieces of massive problems show that overarching crises may be less hopeless than they appear.
Antidepressants bring in almost $17 billion a year for the pharmaceutical industry, and yet science shows their benefit to be small. Natural therapies such as diet, exercise, light therapy and cognitive behavioural therapy are just as effective.
These four “natural” therapies for depression have rigorous, peer-reviewed scientific studies to support their use.
It doesn’t look like a kidney, but this ‘kidney-on-a-chip’ is a breakthrough for new drug testing.
Researchers who've created a kidney-on-a-chip explain why these kinds of devices are an improvement over traditional ways to test new drugs.
High-tech ways to scan nature’s own creations.
Pharmaceutical companies focus on small molecules they've devised – and can easily patent. But nature's already come up with many antibacterial compounds that drug designers could use to make medicines.
Health Canada’s intention to increase the fees drug makers pay for the drug approval process threatens to compromise drug safety and the health of the Canadian public.
Health Canada proposes to increase fees to the pharmaceutical industry for prescription drug approval. This will compromise drug safety and is a risk to the health of the Canadian public.
The cells inside this bioreactor are the real pharmaceutical factories.
Rather than being designed by chemists, this class of pharmaceuticals is produced by living cells. Here's where they come from and how they work.
Are research nonprofits holding up their end of the tax-exempt bargain?
Holding patents can be a lucrative and powerful position to be in. Here's a proposal for how nonprofit patent holders can do more for the common good – and live up to their end of the tax break bargain.
Drug-resistant strains of gonorrhoea, once easily dispatched with penicillin, are spreading across the globe resulting in chronic pain and sterility.
Without leading edge innovations and coordination, Canadians will die from the epidemic of antibiotic resistant infections.
Now you can find out who’s wining and dining our doctors, nurses and pharmacists with publicly available data of drug company funded events.
Drug companies funded more than 116,000 educational events for doctors over four years. Now you can find out exactly which companies footed the bills and how much they paid.
Globalised drug manufacturing is adding to the problem of antimicrobial resistance.
If doctors prescribe generic drugs rather than their brand name equivalents, most times patients benefit.
A push towards prescribing generic medications rather than their branded equivalents, as flagged in the budget, may have benefits beyond simple cost savings.
The government is paying too much for pharmaceuticals that are no better than their cheaper counterparts. Let’s fix that.
Australia is spending more than A$500 million a year too much for pharmaceuticals because of a little known loophole that allows drug companies to overcharge the government.
Firms with a focus on the domestic and regional market have an incentive to distribute their medicines effectively. Local production can create a win-win situation for health and employment.